http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 21 Aug 2025 09:01:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++Turnstone+Biologics+Corp+++++++++++++/25233593.html si-local-file:///var/storage/secattach/20250821/25233593.html http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++Turnstone+Biologics+Corp+++++++++++++/25233593.html Thu, 21 Aug 2025 09:01:00 -0400 TSBX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Turnstone+Biologics+Corp++For%3A+Aug+08++Filed+by%3A+ORBIMED+ADVISORS+LLC/25190130.html si-local-file:///var/storage/secattach/20250812/25190130.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Turnstone+Biologics+Corp++For%3A+Aug+08++Filed+by%3A+ORBIMED+ADVISORS+LLC/25190130.html Tue, 12 Aug 2025 17:22:00 -0400 TSBX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Turnstone+Biologics+Corp+++++++++++++++Filed+by%3A+Versant+Venture+Capital+V%2C+L.P./25189617.html si-local-file:///var/storage/secattach/20250812/25189617.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Turnstone+Biologics+Corp+++++++++++++++Filed+by%3A+Versant+Venture+Capital+V%2C+L.P./25189617.html Tue, 12 Aug 2025 16:45:00 -0400 TSBX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Turnstone+Biologics+Corp++For%3A+Aug+08++Filed+by%3A+Versant+Vantage+II%2C+L.P./25189459.html si-local-file:///var/storage/secattach/20250812/25189459.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Turnstone+Biologics+Corp++For%3A+Aug+08++Filed+by%3A+Versant+Vantage+II%2C+L.P./25189459.html Tue, 12 Aug 2025 16:35:00 -0400 TSBX http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++Turnstone+Biologics+Corp+++++++++++++/25181803.html si-local-file:///var/storage/secattach/20250811/25181803.html http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++Turnstone+Biologics+Corp+++++++++++++/25181803.html Mon, 11 Aug 2025 16:50:00 -0400 TSBX http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++Turnstone+Biologics+Corp+++++++++++++/25181787.html si-local-file:///var/storage/secattach/20250811/25181787.html http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++Turnstone+Biologics+Corp+++++++++++++/25181787.html Mon, 11 Aug 2025 16:49:00 -0400 TSBX http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Turnstone+Biologics+Corp++For%3A+Aug+11/25179199.html si-local-file:///var/storage/secattach/20250811/25179199.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Turnstone+Biologics+Corp++For%3A+Aug+11/25179199.html Mon, 11 Aug 2025 10:31:00 -0400 TSBX http://www.streetinsider.com/SEC+Filings/Form++SC+14D9A++Turnstone+Biologics+Corp+++++++++++++++Filed+by%3A+Turnstone+Biologics+Corp./25179072.html si-local-file:///var/storage/secattach/20250811/25179072.html http://www.streetinsider.com/SEC+Filings/Form++SC+14D9A++Turnstone+Biologics+Corp+++++++++++++++Filed+by%3A+Turnstone+Biologics+Corp./25179072.html Mon, 11 Aug 2025 10:04:00 -0400 TSBX http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++Turnstone+Biologics+Corp+++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/25178932.html si-local-file:///var/storage/secattach/20250811/25178932.html http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++Turnstone+Biologics+Corp+++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/25178932.html Mon, 11 Aug 2025 09:39:00 -0400 TSBX http://www.streetinsider.com/SEC+Filings/Form++SC+TO-TA++Turnstone+Biologics+Corp+++++++++++++++Filed+by%3A+XOMA+Royalty+Corp/25178769.html si-local-file:///var/storage/secattach/20250811/25178769.html http://www.streetinsider.com/SEC+Filings/Form++SC+TO-TA++Turnstone+Biologics+Corp+++++++++++++++Filed+by%3A+XOMA+Royalty+Corp/25178769.html Mon, 11 Aug 2025 09:15:00 -0400 TSBX http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html <p align="center"><em>- Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right -</em></p> <p>EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Turnstone Biologics Corp. (NASDAQ: TSBX) common stock for a price per share of $0.34 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR” and http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html Mon, 11 Aug 2025 09:00:00 -0400 A.07414818 A.12939998 O.00036195 O.03227691 O.20113046 TSBX XOMA XOMAO XOMAP http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html <p align="center"><em>- Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right -</em></p> <p>EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Turnstone Biologics Corp. (NASDAQ: TSBX) common stock for a price per share of $0.34 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR” and http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html Mon, 11 Aug 2025 09:00:00 -0400 A.07414818 A.12939998 O.00036195 O.03227691 O.20113046 TSBX XOMA XOMAO XOMAP http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html <p align="center"><em>- Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right -</em></p> <p>EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Turnstone Biologics Corp. (NASDAQ: TSBX) common stock for a price per share of $0.34 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR” and http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html Mon, 11 Aug 2025 09:00:00 -0400 A.07414818 A.12939998 O.00036195 O.03227691 O.20113046 TSBX XOMA XOMAO XOMAP http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html <p align="center"><em>- Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right -</em></p> <p>EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Turnstone Biologics Corp. (NASDAQ: TSBX) common stock for a price per share of $0.34 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR” and http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html Mon, 11 Aug 2025 09:00:00 -0400 A.07414818 A.12939998 O.00036195 O.03227691 O.20113046 TSBX XOMA XOMAO XOMAP http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html <p align="center"><em>- Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right -</em></p> <p>EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Turnstone Biologics Corp. (NASDAQ: TSBX) common stock for a price per share of $0.34 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR” and http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html Mon, 11 Aug 2025 09:00:00 -0400 A.07414818 A.12939998 O.00036195 O.03227691 O.20113046 TSBX XOMA XOMAO XOMAP http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html <p align="center"><em>- Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right -</em></p> <p>EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Turnstone Biologics Corp. (NASDAQ: TSBX) common stock for a price per share of $0.34 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR” and http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html Mon, 11 Aug 2025 09:00:00 -0400 A.07414818 A.12939998 O.00036195 O.03227691 O.20113046 TSBX XOMA XOMAO XOMAP http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html <p align="center"><em>- Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right -</em></p> <p>EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Turnstone Biologics Corp. (NASDAQ: TSBX) common stock for a price per share of $0.34 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR” and http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html Mon, 11 Aug 2025 09:00:00 -0400 A.07414818 A.12939998 O.00036195 O.03227691 O.20113046 TSBX XOMA XOMAO XOMAP http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html <p align="center"><em>- Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right -</em></p> <p>EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Turnstone Biologics Corp. (NASDAQ: TSBX) common stock for a price per share of $0.34 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR” and http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html Mon, 11 Aug 2025 09:00:00 -0400 A.07414818 A.12939998 O.00036195 O.03227691 O.20113046 TSBX XOMA XOMAO XOMAP http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html <p align="center"><em>- Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right -</em></p> <p>EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Turnstone Biologics Corp. (NASDAQ: TSBX) common stock for a price per share of $0.34 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR” and http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html Mon, 11 Aug 2025 09:00:00 -0400 A.07414818 A.12939998 O.00036195 O.03227691 O.20113046 TSBX XOMA XOMAO XOMAP http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html <p align="center"><em>- Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right -</em></p> <p>EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Turnstone Biologics Corp. (NASDAQ: TSBX) common stock for a price per share of $0.34 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR” and http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html Mon, 11 Aug 2025 09:00:00 -0400 A.07414818 A.12939998 O.00036195 O.03227691 O.20113046 TSBX XOMA XOMAO XOMAP http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html <p align="center"><em>- Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right -</em></p> <p>EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Turnstone Biologics Corp. (NASDAQ: TSBX) common stock for a price per share of $0.34 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR” and http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html Mon, 11 Aug 2025 09:00:00 -0400 A.07414818 A.12939998 O.00036195 O.03227691 O.20113046 TSBX XOMA XOMAO XOMAP http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html <p align="center"><em>- Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right -</em></p> <p>EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Turnstone Biologics Corp. (NASDAQ: TSBX) common stock for a price per share of $0.34 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR” and http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html Mon, 11 Aug 2025 09:00:00 -0400 A.07414818 A.12939998 O.00036195 O.03227691 O.20113046 TSBX XOMA XOMAO XOMAP http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html <p align="center"><em>- Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right -</em></p> <p>EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Turnstone Biologics Corp. (NASDAQ: TSBX) common stock for a price per share of $0.34 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR” and http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html Mon, 11 Aug 2025 09:00:00 -0400 A.07414818 A.12939998 O.00036195 O.03227691 O.20113046 TSBX XOMA XOMAO XOMAP http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html <p align="center"><em>- Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right -</em></p> <p>EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Turnstone Biologics Corp. (NASDAQ: TSBX) common stock for a price per share of $0.34 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR” and http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html Mon, 11 Aug 2025 09:00:00 -0400 A.07414818 A.12939998 O.00036195 O.03227691 O.20113046 TSBX XOMA XOMAO XOMAP http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html <p align="center"><em>- Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right -</em></p> <p>EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Turnstone Biologics Corp. (NASDAQ: TSBX) common stock for a price per share of $0.34 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR” and http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Announces+Closing+of+Tender+Offer+for+Turnstone+Biologics/25178521.html Mon, 11 Aug 2025 09:00:00 -0400 A.07414818 A.12939998 O.00036195 O.03227691 O.20113046 TSBX XOMA XOMAO XOMAP